Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000284833 | SCV000336847 | benign | not specified | 2015-11-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000987802 | SCV000461041 | benign | Autosomal recessive ataxia, Beauce type | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000268635 | SCV000461042 | benign | Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001697636 | SCV000524866 | benign | not provided | 2020-11-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26539891) |
Labcorp Genetics |
RCV000549619 | SCV000649089 | benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987802 | SCV001137258 | benign | Autosomal recessive ataxia, Beauce type | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000284833 | SCV001474829 | benign | not specified | 2019-10-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697636 | SCV002545460 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | SYNE1: BS1, BS2 |
Molecular Genetics, |
RCV003993915 | SCV004812504 | benign | Arthrogryposis multiplex congenita 3, myogenic type | 2023-05-04 | criteria provided, single submitter | clinical testing | South Asian population frequency is 2.65% (859/30,614 alleles, 21 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as BENIGN. Following criteria are met: BA1 |
Lupski Lab, |
RCV000454154 | SCV000537983 | likely pathogenic | Abnormal brain morphology | flagged submission | research |